CDC COCA Call: Update on Ebola Diagnostics at the State and Federal Levels in the United States

Elemento

Click for External Resource*

https://emergency.cdc.gov/coca/calls/2019/callinfo_121919.asp

A few minutes before the webinar begins on Thursday, December 19, 2019, please click the link below to join the webinar:
https://zoom.us/j/804256797external icon

Or iPhone one-tap:
US: +16468769923,,779319056# or +16699006833,,779319056#

Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 646 876 9923 or +1 669 900 6833

Webinar ID: 804 256 797

International numbers available: https://zoom.us/u/anixAVglVexternal icon

The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.

Item Type

Webinar

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.

Share this page:

Facebook Twitter e-mail

Was this resource helpful?

Título

CDC COCA Call: Update on Ebola Diagnostics at the State and Federal Levels in the United States

Materia

Laboratory

Descripción

Overview

Due to the ongoing Ebola virus disease (Ebola) outbreak in the Democratic Republic of the Congo, subject matter experts from the Centers for Disease Control and Prevention (CDC) will discuss the current status of Ebola diagnostic testing that is available through the Laboratory Response Network (LRN) and CDC in the United States. The presenters will also discuss considerations around using OraQuick® Ebola Rapid Antigen Test (RDT), the first Ebola RDT that FDA has allowed for marketing in the United States.

During this COCA Call, clinicians will learn about options for testing for suspected Ebola virus infection in coordination with state and local public health authorities and CDC, as well as the benefits and limitations of existing diagnostic tools.

Autor

CDC

Fecha

2019-12-19

Duración

1 hr: Time: 2:00pm-3:00pm (Eastern Time)

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

Cite background information on the topic covered during the presentation.
Discuss CDC’s role in the topic covered during the presentation.
Describe the topic’s implications for clinicians.
Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

Activity Specific Objectives

Discuss procedures for assessing ill travelers returning from the outbreak area, including consultation with relevant public health authorities.
Describe CDC’s role in providing technical support and testing approval for persons under investigation (PUI) for Ebola virus infection.
Review the procedure for reporting and consulting on a suspected case of Ebola in the United States.
Discuss considerations and limitations for domestic use of novel rapid diagnostic tests for Ebola.
Discuss how to coordinate between clinicians, state health departments, and CDC as it pertains to domestic Ebola preparedness and diagnostics.

Tipo de evento

COCA Call